IGF1 and migraine disorder: These include standard intratympanic corticosteroids (ITS), hyperbaric oxygen therapy (HT), novel pharmacologic agents [e.g., insulin-like growth factor 1 (IGF-1), diuretics, urokinase, and migraine medications], surgical approaches, and targeted drug delivery systems (1, 7–11).